SEOM clinical guidelines on cardiovascular toxicity (2018).

Area of Science:

• Oncology
• Cardiology
• Clinical Guidelines

Background:

• Cardiovascular disease is a frequent and serious side effect of cancer treatment.
• It can stem from direct treatment toxicity or exacerbate pre-existing risk factors.
• Managing cancer treatment-related cardiovascular complications lacks robust scientific evidence, relying on expert consensus.

Purpose of the Study:

• To provide evidence-based recommendations for managing cardiovascular complications in cancer patients.
• To establish a clinical guideline for supportive care in oncology.
• To address the gap in scientific literature regarding cardiotoxicity management.

Main Methods:

• Development of a clinical guideline based on expert consensus.
• Review of existing literature on cancer treatment and cardiovascular disease.
• Synthesis of expert opinions to formulate recommendations.

Main Results:

• Identification of cardiotoxicity as a significant concern for cancer survivors.
• Acknowledgement of the limited scientific evidence in this field.
• Establishment of consensus-based recommendations for clinical practice.

Conclusions:

• Cardiovascular disease is a critical issue in cancer survivorship.
• There is a need for improved management strategies and further research.
• This guideline aims to enhance supportive care for cancer patients experiencing cardiotoxicity.